In order to enhance transparency, a number of changes are being introduced on this Register, notably by improving data availability and reliability. It is expected that this process will be completed by 31 December 2016. Until then, information published on individual expert groups and/or on expert group members may still be missing, be inaccurate or incomplete.
Group Details - Commission Expert Group Return to News section
Print as PDF
Additional Information
Expert group on Corporate Responsibility in the field of Pharmaceuticals (E02558)
Group which operates on a permanent basis
Policy Area:
Public Health
Lead DG:
GROW - DG Internal Market, Industry, Entrepreneurship and SMEs
Associated DG:
EMPL - DG Employment, Social Affairs and Inclusion
RTD - DG Research and Innovation
FISMA - DG Financial Stability, Financial Services and Capital Markets Union
SANTE - DG Health and Food Safety
TRADE - DG Trade
DEVCO - DG International Cooperation and Development
CNECT - DG Communications Networks, Content and Technology
Informal, Temporary
Considering the contribution that medicines provide to the health of individuals, it is necessary to ensure that the pharmaceutical industry strategies are in line with the public health and societal needs and that all partners exercise their responsibilities. The Process on Corporate Responsibility in the field of Pharmaceuticals was set up to initiate a momentum among the Member States, industry and other relevant stakeholders by considering in a balanced approach societal and industrial challenges.
Coordinate with Member States, exchange of views
Publication in RegExp:
11 Jan 2011
Link to Website:
Last updated:
19 Jan 2015
Home   -   top